NO20071294L - Apparat og fremgangsmate for transdermal levering av natriuretiske peptider. - Google Patents

Apparat og fremgangsmate for transdermal levering av natriuretiske peptider.

Info

Publication number
NO20071294L
NO20071294L NO20071294A NO20071294A NO20071294L NO 20071294 L NO20071294 L NO 20071294L NO 20071294 A NO20071294 A NO 20071294A NO 20071294 A NO20071294 A NO 20071294A NO 20071294 L NO20071294 L NO 20071294L
Authority
NO
Norway
Prior art keywords
natriuretic peptide
contained
transdermal delivery
natriuretic peptides
microprotection
Prior art date
Application number
NO20071294A
Other languages
English (en)
Inventor
Peter E Daddona
Yuh-Fun Maa
Marika Kamberi
Scott Sellers
Vidhya Gopalakrishnan
B Michael Silber
Frank Stonebanks
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20071294L publication Critical patent/NO20071294L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En innretning og fremgangsmåte for transdermal avlevering av et natriuretisk peptid som omfatter et avleveringssystem som har et mikrofremspringselement som innbefatter et stort antall mikrofremspring (eller rekker derav) som er egnet til å gjennombore stratum corneum inn i det underliggende epidermislaget, eller epidermis og dermislagene. I en utførelsesform, inneholdes det natriuretiske peptidet i et biokompatibelt belegg som er påført mikrofremspringselementet. I ytterligere en utførelsesform, innbefatter avleveringssystemet en hydrogelformulering som inneholder et natriuretisk peptid. I en alternativ utførelsesform, inneholdes det natriuretiske peptidet både i belegget og hydrogelformuleringen. I ytterligere en annen utførelsesform, inneholdes det natriuretiske peptidet i en faststofformulering.
NO20071294A 2004-08-11 2007-03-09 Apparat og fremgangsmate for transdermal levering av natriuretiske peptider. NO20071294L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60056004P 2004-08-11 2004-08-11
PCT/US2005/028693 WO2006020841A2 (en) 2004-08-11 2005-08-10 Apparatus and method for transdermal delivery of natriuretic peptides

Publications (1)

Publication Number Publication Date
NO20071294L true NO20071294L (no) 2007-05-10

Family

ID=35466467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071294A NO20071294L (no) 2004-08-11 2007-03-09 Apparat og fremgangsmate for transdermal levering av natriuretiske peptider.

Country Status (13)

Country Link
US (1) US20060034903A1 (no)
EP (1) EP1778203A2 (no)
JP (1) JP2008509746A (no)
KR (1) KR20070042573A (no)
CN (1) CN101232874A (no)
AR (1) AR050292A1 (no)
AU (1) AU2005272700A1 (no)
CA (1) CA2576852A1 (no)
IL (1) IL181268A0 (no)
MX (1) MX2007001667A (no)
NO (1) NO20071294L (no)
TW (1) TW200616660A (no)
WO (1) WO2006020841A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
US7795221B2 (en) * 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs
WO2007115175A2 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
US20070249988A1 (en) * 2006-04-21 2007-10-25 Alza Corporation Electrotransport Delivery of Nesiritide
US9987475B2 (en) 2006-07-03 2018-06-05 Lotte Chemical Corporation Micro needle roller assembly
EP2234603A1 (en) * 2007-12-19 2010-10-06 EKR Therapeutics, Inc. Room temperature stable, lyophilized natriuretic peptide formulations
SG173160A1 (en) * 2009-01-30 2011-08-29 Hisamitsu Pharmaceutical Co Microneedle device
DK2457581T3 (da) * 2009-07-23 2014-03-31 Igisu Co Ltd Sammensætning omfattende CNP eller BNP for et udvendigt præparat til hud til behandling af dermatitis
BR112012004058A2 (pt) 2009-08-27 2021-08-17 Kyoko Endo preparação terapêutica para rinite
CN102770176B (zh) * 2010-02-24 2015-11-25 久光制药株式会社 微针装置及其制造方法
HUE035584T2 (en) * 2011-01-21 2018-05-28 Igisu Co Ltd A therapeutic agent for the treatment of allopathy
CN105025942B (zh) * 2012-12-07 2017-11-14 堪萨斯州立大学研究基金会 肽‑白蛋白水凝胶的性能及其应用
CN107709352A (zh) 2015-05-29 2018-02-16 Igisu株式会社 环肽以及含有该环肽的药物、外用剂和化妆品

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
WO1998028037A1 (en) * 1996-12-20 1998-07-02 Alza Corporation Device and method for enhancing transdermal agent flux
US6211296B1 (en) * 1998-11-05 2001-04-03 The B. F. Goodrich Company Hydrogels containing substances
JP4237375B2 (ja) * 2000-03-31 2009-03-11 アスビオファーマ株式会社 虚血性疾患の処置又は予防に用いる医薬組成物
DE60129585T2 (de) * 2000-09-08 2008-04-17 Alza Corp., Mountain View Transdermale vorrichtung
ES2437565T3 (es) * 2003-06-30 2014-01-13 Alza Corporation Formulaciones para microproyecciones revestidas que contienen contraiones no volátiles
WO2005004729A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Method for coating skin piercing microprojections
CN1863572A (zh) * 2003-08-04 2006-11-15 阿尔扎公司 提高药剂经皮流通量的方法和装置
KR20060099523A (ko) * 2003-10-31 2006-09-19 알자 코포레이션 미세 돌출부 어레이를 위한 자가 작동 어플리케이터
CA2552754A1 (en) * 2004-01-09 2005-08-04 Alza Corporation Frequency assisted transdermal agent delivery method and system
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
WO2006130869A1 (en) * 2005-06-02 2006-12-07 Alza Corporation Method for terminal sterilization of transdermal delivery devices

Also Published As

Publication number Publication date
KR20070042573A (ko) 2007-04-23
US20060034903A1 (en) 2006-02-16
JP2008509746A (ja) 2008-04-03
TW200616660A (en) 2006-06-01
WO2006020841A2 (en) 2006-02-23
IL181268A0 (en) 2007-07-04
AU2005272700A1 (en) 2006-02-23
MX2007001667A (es) 2007-10-02
EP1778203A2 (en) 2007-05-02
CA2576852A1 (en) 2006-02-23
AR050292A1 (es) 2006-10-11
WO2006020841A3 (en) 2007-08-16
CN101232874A (zh) 2008-07-30

Similar Documents

Publication Publication Date Title
NO20071294L (no) Apparat og fremgangsmate for transdermal levering av natriuretiske peptider.
MXPA06013168A (es) Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
WO2005099751A3 (en) Apparatus and method for transdermal delivery of influenza vaccine
EP2001453A4 (en) APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE AGENTS FOR TREATING OR PREVENTING OSTEOPENIA
TW200600107A (en) Apparatus and method for transdermal delivery of multiple vaccines
WO2005102334A3 (en) Apparatus and method for transdermal delivery of fentany-based agents
WO2005069758A3 (en) Frequency assisted transdermal agent delivery method and system
WO2005051455A3 (en) Ultrasound assisted transdermal vaccine delivery method and system
TW200618830A (en) Micorprojection apparatus and system with low infection potential
WO2005042054A3 (en) Pretreatment method and system for enhancing transdermal drug delivery
NO20071469L (no) Mikroprojeksjonsarraydel for transdermal levering av vaskulaere endoteliale vekstfaktorer.
US9782574B2 (en) Force-controlled applicator for applying a microneedle device to skin
TW200502017A (en) Active agent delivery device having composite members
WO2007011788A3 (en) Skin penetrating device and method of use
WO2005041871A3 (en) Apparatus and method for enhancing transdermal drug delivery
KR20180125980A (ko) 마이크로니들 입자, 조성물, 및 치료방법 및 관심물질 전달방법
WO2009158411A3 (en) System for anchoring medical devices
AR047229A1 (es) Administracion de conjugados polimericos de peptidos y proteinas terapeuticos por medio de microproyecciones revestidas
EA200601129A1 (ru) Способ лечения нежелательного эффекта при чрескожной доставке лекарства (варианты)
US8404255B2 (en) System and method for transdermal drug delivery
WO2006089056A3 (en) Apparatus and method for transdermal delivery of erythropoetin-based agents
Fujimoto et al. Effect of microdermabrasion on barrier capacity of stratum corneum
TW200602019A (en) Apparatus and method for transdermal delivery of parathyroid hormone agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application